Lysine suppresses myofibrillar protein degradation by regulating the autophagic-lysosomal system through phosphorylation of Akt in C2C12 cells

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Sato, Tomonori ^a   Ito, Yoshiaki ^a   Nagasawa, Takashi ^a  

^a IWATE UNIVERSITY   (Japan)

Author keywords

Akt; AMPK; C2C12; Lysine; Proteolysis

Indexed keywords

EID: 84933048076     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-584     Document Type: Article

References (39)

1. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, Ogier-Denis E: The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway.J Biol Chem 2001, 276:35243–35246. 10.1074/jbc.C100319200
2. Bertrand L, Horman S, Beauloye C, Vanoverschelde JL: Insulin signalling in the heart.Cardiovasc Res 2008, 79:238–248. 10.1093/cvr/cvn093
3. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS: AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.J Biol Chem 2002, 277:23977–23980. 10.1074/jbc.C200171200
4. Coëffier M, Claeyssens S, Bensifi M, Lecleire S, Boukhettala N, Maurer B, Donnadieu N, Lavoinne A, Cailleux AF, Déchelotte P: Influence of leucine on protein metabolism, phosphokinase expression, and cell proliferation in human duodenum.Am J Clin Nutr 2011, 93:1255–1262. 10.3945/ajcn.111.013649
5. Du M, Shen QW, Zhu MJ, Ford SP: Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.J Anim Sci 2007, 85:919–927.
6. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L, Rider MH: Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.J Biol Chem 2006, 281:5335–5340.
7. Ishida A, Kyoya T, Nakashima K, Katsumata M: Muscle protein metabolism during compensatory growth with changing dietary lysine levels from deficient to sufficient in growing rats.J Nutr Sci Vitaminol 2011, 57:401–408. 10.3177/jnsv.57.401
8. Jamart C, Francaux M, Millet GY, Deldicque L, Frère D, Féasson L: Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running.J Appl Physiol 2012, 112:1529–1537. 10.1152/japplphysiol.00952.2011
9. Janku F, McConkey DJ, Hong DS, Kurzrock R: Autophagy as a target for anticancer therapy.Nat Rev Clin Oncol 2011, 8:528–539. 10.1038/nrclinonc.2011.71
10. Kim JS, Wilson JM, Lee SR: Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants.J Nutr Biochem 2009, 21:1–13.
11. Kimball SR, Shantz LM, Horetsky RL, Jefferson LS: Leucine regulates translation of specific mRNAs in L6 myoblasts though mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6.J Biol Chem 1999, 274:11647–11652. 10.1074/jbc.274.17.11647
12. Koopman R, van Loon LJ: Aging, exercise, and muscle protein metabolism.J Appl Physiol 2009, 106:2040–2048. 10.1152/japplphysiol.91551.2008
13. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR: Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart.J Biol Chem 2003, 278:39422–39427. 10.1074/jbc.M305371200
14. Lang SM, Kazi AA, Hong-Brown L, Lang CH: Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice.PLoS ONE 2012, 7:e38910. 10.1371/journal.pone.0038910
15. Lee MY, Jo SD, Lee JH, Han HJ: L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.J Cell Biochem 2008, 105:1410–1419. 10.1002/jcb.21959
16. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, Sandri M: FoxO3 controls autophagy in skeletal muscle in vivo.Cell Metab 2008, 6:458–471.
17. Mascher H, Andersson H, Nilsson PA, Ekblom B, Blomstrand E: Change in signaling pathways regulating protein synthesis in human muscle in the recovery period after endurance exercise.Acta Physiol 2007, 191:67–75. 10.1111/j.1748-1716.2007.01712.x
18. Mordier S, Deval C, Béchet D, Tassa A, Ferrara M: Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway.J Biol Chem 2000, 275:29900–29906. 10.1074/jbc.M003633200
19. Nagao K, Bannai M, Seki S, Kawai N, Mori M, Takahashi M: Voluntary wheel running is beneficial to the amino acid profile of lysine-deficient rats.Am J Physiol Endocrinol Metab 2010, 298:E1170-E1178. 10.1152/ajpendo.00763.2009
20. Nagasawa T, Kido T, Yoshizawa F, Ito Y, Nishizawa N: Rapid suppression of protein degradation in skeletal muscle after oral feeding of leucine in rats.J Nutr Biochem 2002, 13:121–127. 10.1016/S0955-2863(01)00209-1
21. Naito T, Kuma A, Mizushima N: Differential contribution of insulin and amino acids to the mTORC1-autophagy pathway in the liver and muscle.J Biol Chem 2013, 288:21074–21081. 10.1074/jbc.M113.456228
22. Nakashima K, Yakabe Y: AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.Biosci Biotechnol Biochem 2007, 71:1650–1656. 10.1271/bbb.70057
23. Sanchez AM, Csibi A, Raibon A, Cornille K, Gay S, Bernardi H, Candau R: AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.J Cell Biochem 2012, 113:695–710. 10.1002/jcb.23399
24. Sato T, Ito Y, Nagasawa T: Regulation of skeletal muscle protein degradation and synthesis by oral administration of lysine in rats.J Nutr Sci Vitaminol (Tokyo) 2013, 59:412–419. 10.3177/jnsv.59.412
25. Sato T, Ito Y, Nedachi T, Nagasawa T: Lysine suppresses protein degradation through autophagic-lysosomal system in C2C12 myotubes.Mol Cell Biochem 2014, 391:37–46. 10.1007/s11010-014-1984-8
26. Seldin MM, Lei X, Tan SY, Stanson KP, Wei Z, Wong GW: Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver.J Biol Chem 2013, 288:36073–36082. 10.1074/jbc.M113.500736
27. Sugawara T, Ito Y, Nishizawa N, Nagasawa T: Supplementation with dietary leucine to a protein-deficient diet suppresses myofibrillar protein degradation in rats.J Nutr Sci Vitaminol 2007, 53:552–555. 10.3177/jnsv.53.552
28. Sugawara T, Ito Y, Nishizawa N, Nagasawa T: Regulation of muscle protein degradation, not synthesis, by dietary leucine in rats fed a protein-deficient diet.Amino Acids 2009, 37:609–616. 10.1007/s00726-008-0180-0
29. Suzuki T, Bridges D, Nakada D, Skiniotis G, Morrison SJ, Lin JD, Saltiel AR, Inoki K: Inhibition of AMPK catabolic action by GSK3.Mol Cell 2013, 50:407–419. 10.1016/j.molcel.2013.03.022
30. Tato I, Bartrons R, Ventura F, Rosa JL: Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling.J Biol Chem 2011, 286:6128–6142. 10.1074/jbc.M110.166991
31. Tisdale MJ: Mechanisms of cancer cachexia.Physiol Rev 2009, 89:381–410. 10.1152/physrev.00016.2008
32. Vary TC, Lynch CJ: Biochemical approaches for nutritional support of skeletal muscle protein metabolism during sepsis.Nutr Res Rev 2004, 17:77–88. 10.1079/NRR200376
33. Welle S: Human Protein Metabolism. Springer-Verlag, New York; 1999:196–227.
34. Wolfe RR: The underappreciated role of muscle in health and disease.Am J Clin Nutr 2006, 84:475–482.
35. Williamson DL, Bolster DR, Kimball SR, Jefferson LS: Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.Am J Physiol Endocrinol Metab 2006, 291:E80-E89. 10.1152/ajpendo.00566.2005
36. Wilson GJ, Layman DK, Moulton CJ, Norton LE, Anthony TG, Proud CG, Rupassara SI, Garlick PJ: Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandial muscle protein synthesis in rats.Am J Physiol Endocrinol Metab 2011, 301:E1236-E1242. 10.1152/ajpendo.00242.2011
37. Young VR, Munro HN: Nτ-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview.Fed Proc 1978, 37:2291–3000.
38. Zeanandin G, Balage M, Schneider SM, Dupont J, Hébuterne X, Mothe-Satney I, Dardevet D: Differential effect of long-term leucine supplementation on skeletal muscle and adipose tissue in old rats: an insulin signaling pathway approach.Age (Dordr) 2012, 34:371–387. 10.1007/s11357-011-9246-0
39. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL: FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.Cell Metab 2007, 6:472–483. 10.1016/j.cmet.2007.11.004